Pugliese D, Privitera G, Armuzzi A. Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease-the IG-IBD LIVE study. Authors' reply. Aliment Pharmacol Ther 2022;56:733-734.
PMID: 35879901